·Î±×ÀÎ Àüü´º½º¿ÀÇǴϾðEnglishÆÊ ¾ÆÄ«µ¥¹ÌÆʽºÅ¸Å¬·´TVÆʵµ¶ó¸®Äí¸£Æ®DPºÎµ¿»êÀλ絿Á¤Event & Çмú¼¼¹Ì³ªµ¶ÀÚÁ¦º¸
°Ë»ö ä¿ëÁ¤º¸ Æĸ¶¸®¼Ä¡¹ÙÀÌ¿À '1õ¸¸ºÒ ¼öÃâÀÇ Å¾' ¼ö»ó ±â»çÀÔ·Â : 23.12.15 08:26:34 0 °¡ ÇÃÄ£Ãß°¡ Áö¼ÓÀûÀÎ ¼öÃâ Áõ°¡¡¦º¸Åø¸®´®Åå½Å Àü¹®±â¾÷ ¼ºÀå [µ¥Àϸ®ÆÊ=À̼®ÁØ ±âÀÚ] Æĸ¶¸®¼Ä¡ÀÇ Åå½ÅºÎ¹® ÀÚȸ»ç Æĸ¶¸®¼Ä¡¹ÙÀÌ¿À(´ëÇ¥ ¹é½Â°É, ¿øÄ¡¿±)´Â Áö³ 14ÀÏ Ãáõ ¼¼Á¾È£ÅÚ¿¡¼ ¿¸° Á¦60ȸ ¹«¿ªÀdz¯ ¹× Á¦7ȸ °¿ø ¼öÃâÀÎÀÇ ³¯ Çà»ç¿¡¼ '1õ¸¸ºÒ ¼öÃâÀÇ Å¾'À» ¼ö»óÇß´Ù°í 15ÀÏ ¹àÇû´Ù. 2019³â º¸Åø¸®´® Åå½Å ¸®¿£Å彺·Î ÇØ¿Ü Ã¹ ¼öÃâÀ» ½ÃÀÛÇÑ Æĸ¶¸®¼Ä¡¹ÙÀÌ¿À´Â Äڷγª ÆÒµ¥¹Í°ú ±¹³»¿Ü °æÁ¦ À§±â¿¡µµ ºÒ±¸ÇÏ°í ¿¬Æò±Õ 70% ÀÌ»óÀÇ ³ôÀº ¸ÅÃâ ½ÅÀå·üÀ» ±â·ÏÇß´Ù. ÃÖ±Ù¿¡´Â Áö¼ÓÀûÀÎ ¼öÃâ Áõ°¡¿¡ ´ëÀÀÇÏ°íÀÚ °¸ª°úÇлê¾÷´ÜÁö¿¡ Á¦2°øÀå Âø°ø½Äµµ °³ÃÖÇß´Ù. Æĸ¶¸®¼Ä¡¹ÙÀÌ¿À °ü°èÀÚ´Â "´ë³»¿Ü ¾î·Á¿î ȯ°æ ¼Ó¿¡¼µµ ±¹°¡ ¼öÃâ ½ÇÀû¿¡ ±â¿©ÇØ ¶æ ±í´Ù. ¾ÕÀ¸·Îµµ ±Û·Î¹ú º¸Åø¸®´®Åå½Å Àü¹®±â¾÷À¸·Î ¼ºÀåÇϱâ À§ÇØ ´õ¿í ´õ ³ë·ÂÇØ ³ª°¡°Ú´Ù"°í ¸»Çß´Ù. ÇÑÆí, Æĸ¶¸®¼Ä¡¹ÙÀÌ¿À´Â º¸Åø¸®´® Åå½Å ¸®¿£Å彺ÁÖ 100´ÜÀ§, 200´ÜÀ§ Á¦Ç°À» »ý»ê, ÇØ¿Ü ¼öÃâÇÏ°í ÀÖ´Ù. X AD Â¥¸Ô´Â Àº±³»ê Ãâ½Ã! À̺¥Æ®Âü¿© ¡æ À̼®ÁØ ±âÀÚ(wiviwivi@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç Æĸ¶¿¡¼¾½Ã¾ÆÄÚ¸®¾Æ MSL ½Å±Ô ä¿ë ¹Ù·Î°¡±â Medical Science Liaison (Oncology) / Head of Market Access & External Affairs / MR(¿µ¾÷ºÎ) ä¿ë ¹Ù·Î°¡±â PMS Lead (Fixed-term) ¹Ù·Î°¡±â °³¹ß±âȹÆÀ BD °æ·Â(7³â ÀÌ»ó)ä¿ë ¹Ù·Î°¡±â Çѱ¹¿¡ÀÚÀÌ Sr. MSL Associate ä¿ë(Á¤±ÔÁ÷) ¹Ù·Î°¡±â ÇØÅÂhtb ÀÍ»ê°øÀå °ü¸®¾à»ç ä¿ë ¹Ù·Î°¡±â Medical Representative (Á¾º´ ¿µ¾÷ - °è¾àÁ÷) ¹Ù·Î°¡±â Senior Regulatory Science Specialist(1Yr) ¹Ù·Î°¡±â Sr. Regulatory Affairs Specialist (18 months contract) ¹Ù·Î°¡±â ´õÇö´ë ¼¿ï ÇÍŸ¹Î ¾à±¹ ÆÄÆ® ¾à»ç ä¿ë ¹Ù·Î°¡±â ÀÓ»óÆÀ PM °æ·Â(2³â ÀÌ»ó) ä¿ë ¹Ù·Î°¡±â ¸¶ÄÉÆà ¾à»ç, Àü¹®¿¬±¸¿ä¿ø ¸ðÁý ¹Ù·Î°¡±â QC, QA, Medical Affairs, MR(º´¿ø¿µ¾÷) ä¿ë ¹Ù·Î°¡±â (Sr.) Local Research Specialist ¹Ù·Î°¡±â Ç°Áú±×·ìÀå(ÀÌ»ç±Þ), °ü¸®¾à»ç ¸ðÁý ¹Ù·Î°¡±â ¢ß¼¿Æ®¸®¿ÂÁ¦¾à ½ÅÀÔ/°æ·Â ¼ö½Ãä¿ë ¹Ù·Î°¡±â Çѱ¹¿¡ÀÚÀÌ Medical Scientific Affair ä¿ë(À°¾ÆÈÞÁ÷´ëü_±â°£Á¦) ¹Ù·Î°¡±â (ÀüºÏ(ÀüÁÖ °ÅÁÖ)) ¿µ¾÷ºÎ ½ÅÀÔ/°æ·ÂÁ÷(ÁÖÀÓ~´ë¸®±Þ) ¸ðÁý ¹Ù·Î°¡±â ¼¿Æ®¸®¿Â 2025³â 1Â÷ ½ÅÀÔ/°æ·Â ¼ö½Ãä¿ë ¹Ù·Î°¡±â [À¯¸í¿Ü±¹°èÁ¦¾à»ç] ½ÅÀÔ¾à»ç & °æ·Â MSL µî ´Ù¼ö ¹Ù·Î°¡±â Medical Representative (Ŭ¸®´Ð ¿µ¾÷ - °è¾àÁ÷) ¹Ù·Î°¡±â Á¦¾à¾à»çä¿ë ¹Ù·Î°¡±â ÀÓ»óÆÀ¿ø(Á¤±ÔÁ÷), RA/QAÆÀ¿ø,PVÆÀ¿ø(°è¾àÁ÷) ä¿ë ¹Ù·Î°¡±â Á¶¾ÆÁ¦¾à Ç°Áú°ü¸®¾à»ç °æ·Â ä¿ë ¹Ù·Î°¡±â Junior Marketing Manager ä¿ë ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : Æĸ¶¸®¼Ä¡¹ÙÀÌ¿À 1õ¸¸ºÒ ¼öÃâÀÇ Å¾ ¼ö»ó URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ Æĸ¶¸®¼Ä¡¹ÙÀÌ¿À '1õ¸¸ºÒ ¼öÃâÀÇ Å¾' ¼ö»ó ±â»çÀÔ·Â : 23.12.15 08:26:34 0 °¡ ÇÃÄ£Ãß°¡ Áö¼ÓÀûÀÎ ¼öÃâ Áõ°¡¡¦º¸Åø¸®´®Åå½Å Àü¹®±â¾÷ ¼ºÀå [µ¥Àϸ®ÆÊ=À̼®ÁØ ±âÀÚ] Æĸ¶¸®¼Ä¡ÀÇ Åå½ÅºÎ¹® ÀÚȸ»ç Æĸ¶¸®¼Ä¡¹ÙÀÌ¿À(´ëÇ¥ ¹é½Â°É, ¿øÄ¡¿±)´Â Áö³ 14ÀÏ Ãáõ ¼¼Á¾È£ÅÚ¿¡¼ ¿¸° Á¦60ȸ ¹«¿ªÀdz¯ ¹× Á¦7ȸ °¿ø ¼öÃâÀÎÀÇ ³¯ Çà»ç¿¡¼ '1õ¸¸ºÒ ¼öÃâÀÇ Å¾'À» ¼ö»óÇß´Ù°í 15ÀÏ ¹àÇû´Ù. 2019³â º¸Åø¸®´® Åå½Å ¸®¿£Å彺·Î ÇØ¿Ü Ã¹ ¼öÃâÀ» ½ÃÀÛÇÑ Æĸ¶¸®¼Ä¡¹ÙÀÌ¿À´Â Äڷγª ÆÒµ¥¹Í°ú ±¹³»¿Ü °æÁ¦ À§±â¿¡µµ ºÒ±¸ÇÏ°í ¿¬Æò±Õ 70% ÀÌ»óÀÇ ³ôÀº ¸ÅÃâ ½ÅÀå·üÀ» ±â·ÏÇß´Ù. ÃÖ±Ù¿¡´Â Áö¼ÓÀûÀÎ ¼öÃâ Áõ°¡¿¡ ´ëÀÀÇÏ°íÀÚ °¸ª°úÇлê¾÷´ÜÁö¿¡ Á¦2°øÀå Âø°ø½Äµµ °³ÃÖÇß´Ù. Æĸ¶¸®¼Ä¡¹ÙÀÌ¿À °ü°èÀÚ´Â "´ë³»¿Ü ¾î·Á¿î ȯ°æ ¼Ó¿¡¼µµ ±¹°¡ ¼öÃâ ½ÇÀû¿¡ ±â¿©ÇØ ¶æ ±í´Ù. ¾ÕÀ¸·Îµµ ±Û·Î¹ú º¸Åø¸®´®Åå½Å Àü¹®±â¾÷À¸·Î ¼ºÀåÇϱâ À§ÇØ ´õ¿í ´õ ³ë·ÂÇØ ³ª°¡°Ú´Ù"°í ¸»Çß´Ù. ÇÑÆí, Æĸ¶¸®¼Ä¡¹ÙÀÌ¿À´Â º¸Åø¸®´® Åå½Å ¸®¿£Å彺ÁÖ 100´ÜÀ§, 200´ÜÀ§ Á¦Ç°À» »ý»ê, ÇØ¿Ü ¼öÃâÇÏ°í ÀÖ´Ù. X AD Â¥¸Ô´Â Àº±³»ê Ãâ½Ã! À̺¥Æ®Âü¿© ¡æ À̼®ÁØ ±âÀÚ(wiviwivi@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç Æĸ¶¿¡¼¾½Ã¾ÆÄÚ¸®¾Æ MSL ½Å±Ô ä¿ë ¹Ù·Î°¡±â Medical Science Liaison (Oncology) / Head of Market Access & External Affairs / MR(¿µ¾÷ºÎ) ä¿ë ¹Ù·Î°¡±â PMS Lead (Fixed-term) ¹Ù·Î°¡±â °³¹ß±âȹÆÀ BD °æ·Â(7³â ÀÌ»ó)ä¿ë ¹Ù·Î°¡±â Çѱ¹¿¡ÀÚÀÌ Sr. MSL Associate ä¿ë(Á¤±ÔÁ÷) ¹Ù·Î°¡±â ÇØÅÂhtb ÀÍ»ê°øÀå °ü¸®¾à»ç ä¿ë ¹Ù·Î°¡±â Medical Representative (Á¾º´ ¿µ¾÷ - °è¾àÁ÷) ¹Ù·Î°¡±â Senior Regulatory Science Specialist(1Yr) ¹Ù·Î°¡±â Sr. Regulatory Affairs Specialist (18 months contract) ¹Ù·Î°¡±â ´õÇö´ë ¼¿ï ÇÍŸ¹Î ¾à±¹ ÆÄÆ® ¾à»ç ä¿ë ¹Ù·Î°¡±â ÀÓ»óÆÀ PM °æ·Â(2³â ÀÌ»ó) ä¿ë ¹Ù·Î°¡±â ¸¶ÄÉÆà ¾à»ç, Àü¹®¿¬±¸¿ä¿ø ¸ðÁý ¹Ù·Î°¡±â QC, QA, Medical Affairs, MR(º´¿ø¿µ¾÷) ä¿ë ¹Ù·Î°¡±â (Sr.) Local Research Specialist ¹Ù·Î°¡±â Ç°Áú±×·ìÀå(ÀÌ»ç±Þ), °ü¸®¾à»ç ¸ðÁý ¹Ù·Î°¡±â ¢ß¼¿Æ®¸®¿ÂÁ¦¾à ½ÅÀÔ/°æ·Â ¼ö½Ãä¿ë ¹Ù·Î°¡±â Çѱ¹¿¡ÀÚÀÌ Medical Scientific Affair ä¿ë(À°¾ÆÈÞÁ÷´ëü_±â°£Á¦) ¹Ù·Î°¡±â (ÀüºÏ(ÀüÁÖ °ÅÁÖ)) ¿µ¾÷ºÎ ½ÅÀÔ/°æ·ÂÁ÷(ÁÖÀÓ~´ë¸®±Þ) ¸ðÁý ¹Ù·Î°¡±â ¼¿Æ®¸®¿Â 2025³â 1Â÷ ½ÅÀÔ/°æ·Â ¼ö½Ãä¿ë ¹Ù·Î°¡±â [À¯¸í¿Ü±¹°èÁ¦¾à»ç] ½ÅÀÔ¾à»ç & °æ·Â MSL µî ´Ù¼ö ¹Ù·Î°¡±â Medical Representative (Ŭ¸®´Ð ¿µ¾÷ - °è¾àÁ÷) ¹Ù·Î°¡±â Á¦¾à¾à»çä¿ë ¹Ù·Î°¡±â ÀÓ»óÆÀ¿ø(Á¤±ÔÁ÷), RA/QAÆÀ¿ø,PVÆÀ¿ø(°è¾àÁ÷) ä¿ë ¹Ù·Î°¡±â Á¶¾ÆÁ¦¾à Ç°Áú°ü¸®¾à»ç °æ·Â ä¿ë ¹Ù·Î°¡±â Junior Marketing Manager ä¿ë ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : Æĸ¶¸®¼Ä¡¹ÙÀÌ¿À 1õ¸¸ºÒ ¼öÃâÀÇ Å¾ ¼ö»ó URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ Æĸ¶¸®¼Ä¡¹ÙÀÌ¿À '1õ¸¸ºÒ ¼öÃâÀÇ Å¾' ¼ö»ó ±â»çÀÔ·Â : 23.12.15 08:26:34 0 °¡ ÇÃÄ£Ãß°¡ Áö¼ÓÀûÀÎ ¼öÃâ Áõ°¡¡¦º¸Åø¸®´®Åå½Å Àü¹®±â¾÷ ¼ºÀå [µ¥Àϸ®ÆÊ=À̼®ÁØ ±âÀÚ] Æĸ¶¸®¼Ä¡ÀÇ Åå½ÅºÎ¹® ÀÚȸ»ç Æĸ¶¸®¼Ä¡¹ÙÀÌ¿À(´ëÇ¥ ¹é½Â°É, ¿øÄ¡¿±)´Â Áö³ 14ÀÏ Ãáõ ¼¼Á¾È£ÅÚ¿¡¼ ¿¸° Á¦60ȸ ¹«¿ªÀdz¯ ¹× Á¦7ȸ °¿ø ¼öÃâÀÎÀÇ ³¯ Çà»ç¿¡¼ '1õ¸¸ºÒ ¼öÃâÀÇ Å¾'À» ¼ö»óÇß´Ù°í 15ÀÏ ¹àÇû´Ù. 2019³â º¸Åø¸®´® Åå½Å ¸®¿£Å彺·Î ÇØ¿Ü Ã¹ ¼öÃâÀ» ½ÃÀÛÇÑ Æĸ¶¸®¼Ä¡¹ÙÀÌ¿À´Â Äڷγª ÆÒµ¥¹Í°ú ±¹³»¿Ü °æÁ¦ À§±â¿¡µµ ºÒ±¸ÇÏ°í ¿¬Æò±Õ 70% ÀÌ»óÀÇ ³ôÀº ¸ÅÃâ ½ÅÀå·üÀ» ±â·ÏÇß´Ù. ÃÖ±Ù¿¡´Â Áö¼ÓÀûÀÎ ¼öÃâ Áõ°¡¿¡ ´ëÀÀÇÏ°íÀÚ °¸ª°úÇлê¾÷´ÜÁö¿¡ Á¦2°øÀå Âø°ø½Äµµ °³ÃÖÇß´Ù. Æĸ¶¸®¼Ä¡¹ÙÀÌ¿À °ü°èÀÚ´Â "´ë³»¿Ü ¾î·Á¿î ȯ°æ ¼Ó¿¡¼µµ ±¹°¡ ¼öÃâ ½ÇÀû¿¡ ±â¿©ÇØ ¶æ ±í´Ù. ¾ÕÀ¸·Îµµ ±Û·Î¹ú º¸Åø¸®´®Åå½Å Àü¹®±â¾÷À¸·Î ¼ºÀåÇϱâ À§ÇØ ´õ¿í ´õ ³ë·ÂÇØ ³ª°¡°Ú´Ù"°í ¸»Çß´Ù. ÇÑÆí, Æĸ¶¸®¼Ä¡¹ÙÀÌ¿À´Â º¸Åø¸®´® Åå½Å ¸®¿£Å彺ÁÖ 100´ÜÀ§, 200´ÜÀ§ Á¦Ç°À» »ý»ê, ÇØ¿Ü ¼öÃâÇÏ°í ÀÖ´Ù. X AD Â¥¸Ô´Â Àº±³»ê Ãâ½Ã! À̺¥Æ®Âü¿© ¡æ À̼®ÁØ ±âÀÚ(wiviwivi@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç
0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : Æĸ¶¸®¼Ä¡¹ÙÀÌ¿À 1õ¸¸ºÒ ¼öÃâÀÇ Å¾ ¼ö»ó URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö